Table S1.
AChR reversal potentials and permeability-coefficient ratios
AChR position –1′ αεαβδ* | Other mutations αεαβδ* | Reversal potential, mean ± SE, mV† | PK+/PCl–, mean ± SE‡ | PCl–/PK+, mean ± SE‡ | n§ |
EQEEE | — | −48.7 ± 0.5 | 97 ± 23 | 0.022 ± 0.005 | 20 |
EQEEE | AAAAA (97/99 ECD) | −49.8 ± 0.3 | 200 ± 72 | 0.007 ± 0.003 | 3 |
QQQQQ | — | −44.3 ± 0.6 | 19 ± 2 | 0.055 ± 0.006 | 3 |
AAAAA | — | −44.8 ± 0.8 | 22 ± 3 | 0.051 ± 0.008 | 5 |
AQAAA | AQAAK (M2 20′) | −43.4 ± 1.1 | 16 ± 2 | 0.065 ± 0.011 | 3 |
AQAAA | AQAAA (M1–M2 –5′) | −44.8 ± 0.3 | 20 ± 1 | 0.050 ± 0.003 | 4 |
AQAAA | AQAAK (M2 20′) + AQAAA (M1–M2 –5′) | −41.5 ± 0.5 | 12 ± 1 | 0.085 ± 0.005 | 3 |
EQEAA | — | −49.4 ± 0.6 | 88 ± 27 | 0.007 ± 0.003 | 4 |
EAEAA | — | −50.2 ± 0.8 | 279 ± 222 | 0.012 ± 0.006 | 5 |
AAAEE | — | −49.2 ± 0.5 | 147 ± 67 | 0.011 ± 0.004 | 4 |
AAADD | — | −45.7 ± 0.9 | 28 ± 7 | 0.042 ± 0.009 | 4 |
DADAD | — | −47.9 ± 2.3 | 30 | 0.040 | 3 |
DADDD | — | −47.7 ± 0.5 | 45 ± 9 | 0.024 ± 0.004 | 3 |
EQEKE | — | −44.8 ± 0.9 | 21 ± 4 | 0.050 ± 0.009 | 3 |
EQEEK | — | −43.9 ± 0.7 | 17 ± 2 | 0.060 ± 0.007 | 4 |
AQAEK | — | −36.1 ± 1.4 | 7.1 ± 1.1 | 0.16 ± 0.02 | 6 |
Steeper gradient | |||||
EQEEE | — | −68.7 ± 0.6 | 110 ± 23 | 0.010 ± 0.002 | 4 |
AAAAA | — | −66.1 ± 1.1 | 55 ± 15 | 0.021 ± 0.004 | 3 |
The amino acids occupying the indicated positions are given for the five muscle-AChR subunits in the order α1, ε, α1, β1, and δ. Mutant residues are given in bold. Positions in and flanking the M2 α-helix are given using the prime notation. ECD, extracellular domain.
The equilibrium (Nernst) potentials at 22 °C, calculated using ion activities, were –50.6 mV for K+, and +46.2 mV for Cl–. For the steeper KCl gradient, these values were –71.7 mV for K+, and +73.1 mV for Cl–.
Means and SEs were calculated as described in detail in SI Materials and Methods. Therefore, the mean values of the permeability ratios in this table (columns 4 and 5) are different from the permeability ratios that could be calculated by applying the GHK equation to the mean reversal potentials (column 3).
Number of independent whole-cell recordings.